Clinical Trials Browser

Observational × Non-Muscle Invasive Bladder Neoplasms × 90 days × Clear all

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Disease Progression

NCT07309445 2026-04-13

Nova-sTAR

Recruiting

150 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT07511517 2026-04-09

BladMetrix

Active not recruiting

500 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Hypersensitivity

NCT07144319 2026-04-01

ENAiBLE

Recruiting

500 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07494864 2026-03-27

MiLUT

Recruiting

800 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT07225127 2026-03-23

CISTO2

Recruiting

408 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT07130578 2026-03-03

The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer

Recruiting

60 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06026332 2026-02-17

ABLE-41

Terminated

202 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06126796 2026-01-23

Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)

Completed

107 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms

Clinical Trials

Tumor Budding and T1 Substaging in Urothelial Bladder Cancer

Nova-sTAR

BladMetrix

ENAiBLE

MiLUT

CISTO2

The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer

ABLE-41

Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)